S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
NASDAQ:NEPH

Nephros (NEPH) Stock Price, News & Analysis

$2.19
-0.08 (-3.52%)
(As of 03/28/2024 ET)
Today's Range
$2.19
$2.35
50-Day Range
$2.11
$3.74
52-Week Range
$1.05
$4.04
Volume
3,277 shs
Average Volume
20,102 shs
Market Capitalization
$23.08 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
NEPH stock logo

About Nephros Stock (NASDAQ:NEPH)

Nephros, Inc. engages in development and sale of high performance water solutions to the medical and commercial markets in the United States. The company operates in two segments: Water Filtration and Renal Products. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company also develops and sells medical device products for patients with renal disease, including a second generation hemodiafiltration system for the treatment of patients with end stage renal disease. In addition, it manufactures and sells water filters that improve the taste and odor of water, as well as reduce biofilm, bacteria, and scale build-up in downstream equipment under the Nephros and Nanoguard brands for the food service, hospitality, convenience store, and health care markets, as well as medical institutions. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.

NEPH Stock Price History

NEPH Stock News Headlines

Nephros Full Year 2023 Earnings: Misses Expectations
Central Banks Preparing for US Dollar Collapse?
China is spearheading this blatant de-dollarization push, dominating the physical gold market through massive central bank buying. Their ultimate goal? Ditching the greenback in favor of local BRICS currencies.
Nephros just upgraded at Benchmark, here's why
Central Banks Preparing for US Dollar Collapse?
China is spearheading this blatant de-dollarization push, dominating the physical gold market through massive central bank buying. Their ultimate goal? Ditching the greenback in favor of local BRICS currencies.
Earnings Outlook For Nephros
Nephros earnings: here's what to expect
What Is Nephros, Inc.'s (NASDAQ:NEPH) Share Price Doing?
Nephros Inc NEPH
Benchmark Co. Keeps Their Hold Rating on Nephros (NEPH)
Breakeven On The Horizon For Nephros, Inc. (NASDAQ:NEPH)
Nephros: Q3 Earnings Insights
See More Headlines
Receive NEPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nephros and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/07/2024
Today
3/29/2024
Next Earnings (Estimated)
5/08/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:NEPH
Employees
27
Year Founded
N/A

Profitability

Net Income
$-1,580,000.00
Pretax Margin
-11.06%

Debt

Sales & Book Value

Annual Sales
$14.24 million
Book Value
$0.80 per share

Miscellaneous

Free Float
10,006,000
Market Cap
$23.09 million
Optionable
Not Optionable
Beta
1.34
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Mr. Robert Banks
    President, CEO & Director
  • Ms. Judy F. Krandel C.F.A. (Age 59)
    Chief Financial Officer
  • Mr. Alfred Vargas
    Director of Operations
  • Brianne McGuire
    Director of Brand, Marketing & Business Development
  • Vashone R. Thomas
    Vice President of Quality, Regulatory, & Human Resources
  • Mr. Daron G. Evans M.B.A. (Age 50)
    M.S., Chief Executive Officer of Specialty Renal Products, Inc
    Comp: $300.18k
  • Mr. Greg Lucas
    President of Aether Water Systems
  • Ms. Judy Mazzini
    Controller

NEPH Stock Analysis - Frequently Asked Questions

How have NEPH shares performed in 2024?

Nephros' stock was trading at $3.46 at the beginning of 2024. Since then, NEPH shares have decreased by 36.7% and is now trading at $2.19.
View the best growth stocks for 2024 here
.

Are investors shorting Nephros?

Nephros saw a decline in short interest in the month of March. As of March 15th, there was short interest totaling 1,800 shares, a decline of 64.7% from the February 29th total of 5,100 shares. Based on an average daily trading volume, of 26,500 shares, the short-interest ratio is currently 0.1 days. Currently, 0.0% of the company's shares are short sold.
View Nephros' Short Interest
.

When is Nephros' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 8th 2024.
View our NEPH earnings forecast
.

How were Nephros' earnings last quarter?

Nephros, Inc. (NASDAQ:NEPH) announced its quarterly earnings data on Thursday, March, 7th. The company reported ($0.06) earnings per share (EPS) for the quarter. The business had revenue of $3.25 million for the quarter. Nephros had a negative net margin of 11.06% and a negative trailing twelve-month return on equity of 18.25%.

Who are Nephros' major shareholders?

Nephros' stock is owned by a variety of retail and institutional investors. Top institutional investors include Wexford Capital LP (35.12%). Insiders that own company stock include Andrew Astor, Robert R Jr Banks, Tom Gwydir and Wesley S Lobo.
View institutional ownership trends
.

How do I buy shares of Nephros?

Shares of NEPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:NEPH) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners